Mekinist Trametinib Tablets In Pakistan
| Size | 30 Tablets |
| Made in | USA |
| Product Condition | Sealed — Brand new. |
| Payment Mode | COD & Bank Transfer |
| Category | Health & Wellness |
| Estimated Delivery | 1–2 Business Days |
Mekinist Trametinib Tablets In Pakistan
brand name. Mekinist generic name. The Trametinib. Class of drugs. targeted treatment (kinase inhibitor/MEK inhibitor). form. Oral tablets (oral solution is also an option). advantages. usually 0.5 mg and 2 mg pills. Mekinist is used to treat some types of cancer. Melanoma, or skin cancer NSCLC, or non-small cell lung cancer Brain tumors (low-grade glioma) and thyroid cancer more solid cancers with certain mutations. Trametinib is a kinase inhibitor found in mekinist. It functions by focusing on and inhibiting particular proteins called MEK1 and MEK2. These proteins are in charge of encouraging cancer cells to proliferate.
How Mekinist Trametinib Works:
focuses on the signaling pathway of MAPK. The MAPK/ERK pathway is frequently used by cancer cells. Cells are instructed to proliferate, divide, and survive by this mechanism. This route is hyperactive in many malignancies, leading to unchecked development. Mekinist selectively suppresses the MEK protein, which is a crucial signaling chain switch. by preventing MEK. Growth signals are disrupted The division of cancer cells slows down or ceases. works particularly in tumors with BRAF mutations. The BRAF gene is mutated in several malignancies.
How To Use Mekinist Trametinib:
Administration. Take with a full glass of water, on an empty stomach, at the same time every day.
Missed Dose. Take it as soon as you remember, unless it is more than 12 hours late; if so, skip it.
Handling. Store tablets in the refrigerator to protected from light and moisture.
Precautions. Do not stop taking this medication without consulting your doctor, even if you feel well.
Contraindications. Do not take if you are allergic to trametinib
Benefits Of Mekinist Trametinib:
Treats advanced or metastatic melanoma (BRAF mutation positive).
Effective in non-small cell lung cancer (NSCLC) with BRAF mutation.
Used in combination with Dabrafenib for better cancer control.
Clinically approved and recommended by oncologists worldwide.
Improves overall survival and progression-free survival rates.
Oral targeted therapy – convenient to take at home.
Helps slow or stop the growth of cancer cells.
Reduces tumor size in some patients.
Customer Reviews
Write a Review
Maqbool
Apr-09-2026Thanks for delivering right time. Appreciate your services. Recommended provides original Products sells all over Pakistan.
Asad
Apr-09-2026Good product, brilliant results.I'm totally satisfied With this Product.
